Management of palmoplantar pustulosis: Do we need to change?

British Journal of Dermatology

Volumn 164, Issue 5, 2011, Pages 942-946

  Mrowietz, U ^a   Van De Kerkhof, P C M ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; REVIEW; SMOKING; STREPTOCOCCUS INFECTION; SWEAT GLAND; TONSILLITIS;

CELIAC DISEASE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; PALATINE TONSIL; PSORIASIS; SMOKING; STREPTOCOCCAL INFECTIONS; SWEAT GLANDS;

EID: 79955428855     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10233.x     Document Type: Review

References (49)

1. Asumalahti K, Laitinen T, Lahermo P, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003; 120: 627-40.
2. Mössner R, Kingo K, Kleensang A, et al. Association of TNF-238 and -308 promotor polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 2005; 124: 282-4. (Pubitemid 40100984)
3. de Waal AC, van de Kerkhof PC,. Pustulosis palmoplantaris is a disease distinct from psoriasis. J Dermatolog Treat 2011; 22: 102-5.
4. MichaÃlsson G, Kristjánsson G, Pihl Lundin I, Hagforsen E,. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol 2007; 156: 659-66. (Pubitemid 46452354)
5. Hradil E, Gentz CF, Matilainen T, et al. Skeletal involvement in pustulosis palmo-plantaris with special reference to the sterno-costo-clavicular joints. Acta Derm Venereol 1988; 68: 65-73. (Pubitemid 18032680)
6. Benhamou CL, Chamot AM, Kahn MF,. Synovitis-acne-pustulosis-hyperostosis- osteomyelitis syndrome (SAPHO): a new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988; 6: 109-12.
7. Farley E, Masrour S, McKey J, Menter A,. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 2009; 60: 1024-31.
8. Rallis E, Korfitis C, Stavropoulou E, Papaconstantis M,. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction? J Dermatolog Treat 2010; 21: 3-5.
9. Seneschal J, Milpied B, Vergier B, et al. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081-8.
10. Mössner R, Thaci D, Mohr J, et al. Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases. Arch Dermatol Res 2008; 300: 101-5.
11. Naldi L, Peli L, Parazzini F,. Association of early stage psoriasis with smoking and male alcohol consumption. Arch Dermatol 1999; 135: 1479-84.
12. Hagforsen E,. The cutaneous non-neuronal cholinergic system and smoking related dermatoses: studies of the psoriasis variant palmoplantar pustulosis. Life Sci 2007; 80: 2227-34. (Pubitemid 46818271)
13. Michaelsson G, Gustafsson K, Hagforsen E,. The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol 2006; 54: 737-8.
14. Hagforsen E, Edvinsson M, Nordlind K, MichaÃlsson G,. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 2002; 146: 383-91. (Pubitemid 34603809)
15. Hagforsen E, Einarsson A, Aronsson F, et al. The distribution of choline acetyltransferase- and acetylcholinesterase-like immunoreactivity in the palmar skin of patients with palmoplantar pustulosis. Br J Dermatol 2000; 142: 234-42. (Pubitemid 30117691)
16. Hagforsen E, MichaÃlsson G, Stridsberg M,. Normal and PPP-affected palmoplantar sweat gland express neuroendocrine markers chromogranins and synaptophysin differently. Arch Dermatol Res 2010; 302: 685-93.
17. Murakami M, Ohtake T, Horibe Y, et al. Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis. J Invest Dermatol 2010; 130: 2010-16.
18. Hagforsen E, Hedstrand H, Nyberg F, MichaÃlsson G,. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis. Br J Dermatol 2010; 163: 572-9.
19. Andrews GC, Machacek GF,. Pustular bacterids of the hands and feet. Arch Dermatol Syphilol 1935; 32: 837-47.
20. Ono T,. Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris. J Dermatol 1977; 4: 163-72. (Pubitemid 8242890)
21. Koshiba S, Ichimiya S, Nagashima T, et al. Tonsillar crypt epithelium of palmoplantar pustulosis secretes interleukin-6 to support B-cell development via p63/p73 transcription factors. J Pathol 2008; 214: 75-84.
22. Nozawa H, Kishibe K, Takahara M, Harabuchi Y,. Expression of cutaneous lymphocyte-associated antigen (CLA) in tonsillar T-cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris (PPP). Clin Immunol 2005; 116: 42-53. (Pubitemid 40733582)
23. Takahara M, Kishibe K, Nozawa H, Harabuchi Y,. Increase of activated T-cells and up-regulation of Smad7 without elevation of TGF-beta expression in tonsils from patients with pustulosis palmaris et plantaris. Clin Immunol 2005; 115: 192-9. (Pubitemid 40693090)
24. Yoshizaki T, Bandoh N, Ueda S, et al. Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris. Clin Exp Immunol 2009; 157: 71-82.
25. Hayashi M, Fujihara K, Beder LB, et al. Pathogenic role of tonsillar lymphocytes in associated with HSP60/65 in pustulosis palmaris et plantaris. Auris Nasus Larynx 2009; 36: 578-85.
26. Sakiyama H, Kobayashi S, Dianzani U, et al. Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. J Dermatol Sci 2008; 50: 197-207. (Pubitemid 351602159)
27. Ueda S, Takahara M, Tohtani T, et al. Up-regulation of β1 integrin on tonsillar T cells and its induction by in vitro stimulation with α-streptococci in patients with pustulosis palmaris et plantaris. J Clin Immunol 2010; 30: 861-71.
28. MichaÃlsson G, Gerdén B,. How common is gluten intolerance among patients with psoriasis? Acta Derm Venereol 1991; 71: 90.
29. MichaÃlsson G, Gerdén B, Ottosson M,. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol 1993; 129: 667-73. (Pubitemid 24003551)
30. Weisenseel P, Kuznetsov AV, Ruzicka T, Prinz JC,. Palmoplantar pustulosis is not inevitably associated with antigliadin antibodies. Br J Dermatol 2007; 156: 1399-400. (Pubitemid 47029840)
31. Rosén K, Lindstedt G, Mobacken H, Nyström E,. Thyroid function in patients with pustulosis palmoplantaris. J Am Acad Dermatol 1998; 19: 1009-16.
32. Gimenez-Garcia R, Sanchez-Ramon S, Cuellar-Olmedo LA,. Palmoplantar pustulosis: a clinicoepidemiological study. The relationship between tobacco use and thyroid function. J Eur Acad Dermatol Venereol 2003; 17: 276-9. (Pubitemid 36575646)
33. Hagforsen E, MichaÃlsson K, Lundgren E, et al. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study. Acta Derm Venereol 2005; 85: 225-32. (Pubitemid 40695165)
34. 4 in pustules. J Am Acad Dermatol 2000; 42: 1021-5. (Pubitemid 30368672)
35. Yanagi T, Shimizu T, Abe R, Shimizu H,. Zinc dental fillings and palmoplantar pustulosis. Lancet 2005; 366: 1050. (Pubitemid 41323041)
36. Chalmers R, Hollis S, Leonardi-Bee J, et al. Interventions for chronic palmoplantar pustulosis. Cochrane Library 2009; 4: 1-49.
37. Adisen E, Tekin O, Gülekon A, Gürer MA,. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol 2009; 23: 814-19.
38. Nast A, Kopp I, Augustin M, et al. German evidence-based guidelines for the treatment of psoriasis vulgaris (short version). Arch Dermatol Res 2007; 299: 111-38. (Pubitemid 46835379)
39. Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
40. Guenther LC,. Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis. J Cutan Med Surg 2007; 11: 202-5.
41. Carr D, Tusa MG, Carroll CL, et al. Open label trial of alefacept in palmoplantar pustular psoriasis. J Dermatolog Treat 2008; 19: 97-100. (Pubitemid 351891548)
42. V'lckova-Laskoska MT, Caca-Biljanovska NG, Laskoski DS, Kamberova SJ,. Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study. Dermatol Ther 2009; 22: 85-9.
43. Mihara M, Hagari Y, Morimura T, et al. Itraconazole as a new treatment for pustulosis palmaris et plantaris. Arch Dermatol 1998; 34: 639-40. (Pubitemid 28222329)
44. Yawalkar N, Hunger RE,. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab. Dermatology 2009; 218: 79-83.
45. Wozel G, Vitez L,. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab. Acta Derm Venereol 2008; 88: 169-70. (Pubitemid 351507195)
46. Bissonnette R, Poulin Y, Bolduc C, et al. Etanercept in the treatment of palmoplantar pustulosis. J Drugs Dermatol 2008; 7: 940-6.
47. Collamer AN, Battafarano DF,. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010; 40: 233-40.
48. Gerdes S, Franke J, Domm S, Mrowietz U,. Ustekinumab in the treatment of palmoplantar pustulosis. Br J Dermatol 2010; 163: 1116-18.
49. Adisen E, Gürer MA,. Therapeutic options for palmoplantar pustulosis. Clin Exp Dermatol 2010; 35: 219-22.